Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Kymera Therapeutics, Inc. has filed 568 SEC EDGAR filings since 22 Jun 2020

SEC filing history

Showing 501-525 of 568 matching filings.

Per page
25
Current page
21
4

FORM 4 SUBMISSION

Filing date
22 Feb 2021
Reporting date
18 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2021
Reporting date
17 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91636

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91636

SC 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91636

SC 13G filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
12 Jan 2021
Reporting date
12 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
05 Nov 2020
Reporting date
05 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
09 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91636

SC 13D

Filing date
03 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
01 Sep 2020
Reporting date
27 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Aug 2020
Reporting date
20 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Aug 2020
Reporting date
20 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91636

THE SCHEDULE 13D

Filing date
25 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
25 Aug 2020
Reporting date
20 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Aug 2020
Reporting date
20 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .